EXHIBIT 12

 

3M COMPANY AND SUBSIDIARIES

 

CALCULATION OF RATIO OF EARNINGS TO FIXED CHARGES

(Millions)

 

 

 

2006

 

2005

 

2004

 

2003

 

2002

 

EARNINGS

 

 

 

 

 

 

 

 

 

 

 

Income before income taxes, minority interest, and cumulative effect of accounting change*

 

$

5,625

 

$

4,828

 

$

4,303

 

$

3,448

 

$

2,775

 

 

 

 

 

 

 

 

 

 

 

 

 

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

139

 

101

 

88

 

103

 

100

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest component of the ESOP benefit expense

 

8

 

10

 

12

 

14

 

16

 

 

 

 

 

 

 

 

 

 

 

 

 

Portion of rent under operating leases representative of the interest component

 

70

 

64

 

60

 

53

 

45

 

 

 

 

 

 

 

 

 

 

 

 

 

Less:

 

 

 

 

 

 

 

 

 

 

 

Equity in undistributed income of 20-50% owned companies

 

6

 

4

 

6

 

7

 

10

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL EARNINGS AVAILABLE FOR FIXED CHARGES

 

 

$ 4,999

$ 4,457

$ 3,611

$ 2,926

 

5,836

 

 

 

 

 

 

 

 

 

 

 

 

 

FIXED CHARGES

 

 

 

 

 

 

 

 

 

 

 

Interest on debt

 

138

 

94

 

78

 

93

 

100

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest component of the ESOP benefit expense

 

8

 

10

 

12

 

14

 

16

 

 

 

 

 

 

 

 

 

 

 

 

 

Portion of rent under operating leases representative of the interest component

 

70

 

64

 

60

 

53

 

45

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL FIXED CHARGES

 

$

216

 

$

168

 

$

150

 

$

160

 

$

161

 

 

 

 

 

 

 

 

 

 

 

 

 

RATIO OF EARNINGS TO FIXED CHARGES

 

27.0

 

29.8

 

29.7

 

22.6

 

18.2

 


* As discussed in Note 1, effective January 1, 2006, 3M adopted SFAS No. 123R. Since 3M elected to use the modified retrospective method, prior periods have been restated resulting in a reduction in earnings and in the ratio of earnings to fixed charges. 2006 results included pre-tax gains of $523 million, with net benefits from gains related to the sale of certain portions of 3M’s branded pharmaceuticals business partially offset by restructuring actions, acquired in-process research and development expenses, settlement costs of a previously disclosed antitrust class action, and environmental obligations related to the pharmaceuticals business. 2003 includes a $93 million pre-tax loss related to an adverse ruling associated with a lawsuit filed by LePage’s Inc. 2002 includes net pre-tax losses of $202 million, primarily related to the 2001/2002 corporate restructuring program.